Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06867484 · ClinicalTrials.gov registry record · NA
Breast Re-irradiation After Second Ipsilateral Lumpectomy
A NA study of Breast Cancer and Cancer, sponsored by Youssef Zeidan.
- Recruiting
- Registry status
- NA
- Development phase
- 114
- Enrollment target
- 2
- Study locations
NCT06867484 is a NA study of Breast Cancer and Cancer that is actively recruiting participants, run by Youssef Zeidan. The registered enrollment target is 114 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT06867484, a NA study of Breast Cancer and Cancer, is actively recruiting participants, sponsored by Youssef Zeidan.
- RECRUITING
- Registry status
- NA
- Development phase
- 114 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.
Conditions Studied
Interventions
- RADIATION Intensity modulated radiation therapy (IMRT)
Study Locations (2)
Florida
- Lynn Cancer Institute at Baptist Health, Inc. - Boca Raton
- Miami Cancer Institute at Baptist Health, Inc. - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2033-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06867484
The ClinicalTrials.gov registry entry for NCT06867484 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Youssef Zeidan, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Intensity modulated radiation therapy (IMRT) is the first listed.
NCT06867484 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06867484 about?
NCT06867484 is a clinical study titled "Breast Re-irradiation After Second Ipsilateral Lumpectomy". The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.
What is the current status of trial NCT06867484?
This trial is currently recruiting. It is a NA study. The enrollment target is 114 participants. The study started on 2025-10-27. Estimated completion is 2033-05.
What conditions does trial NCT06867484 study?
This clinical trial studies the following conditions: Breast Cancer, Cancer, HER2-Negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, Cancer of the Breast.
What interventions are being tested in trial NCT06867484?
The interventions under investigation include: Intensity modulated radiation therapy (IMRT) (RADIATION).
Who is sponsoring clinical trial NCT06867484?
This trial is sponsored by Youssef Zeidan, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06867484 being conducted?
This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.